Crestor Atherosclerosis Indication Adds Point Of Difference, Brand Leader Says
This article was originally published in The Pink Sheet Daily
Executive Summary
AstraZeneca will build atherosclerosis benefit of Crestor into “messaging” of the statin to physicians, Commercial Brand Leader Nanfra says in an interview with “The Pink Sheet” DAILY.